A-319

BIOLOGICAL2 trials

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions

Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus

Early Phase 1

Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis

RecruitingNCT07347860

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRheumatoid Arthritis (RA)

Start: 2026-01-08End: 2027-08-01Target: 12Updated: 2026-01-16

Phase 1

Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus

RecruitingNCT06400537

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologySystemic Lupus Erythematosus

Start: 2024-07-20End: 2026-12-31Target: 25Updated: 2025-09-17

Related Papers

A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial

Nature Medicine2026-09-10